N-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyridin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-c]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-6-methylimidazo[1,2-a]pyridin-3-amine;2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-N-propan-2-ylimidazo[1,2-a]pyridin-3-amine

C108H118N22O5 — CID 157192056

IUPACN-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyridin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-c]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-6-methylimidazo[1,2-a]pyridin-3-amine;2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-N-propan-2-ylimidazo[1,2-a]pyridin-3-amine
SMILESCCCCNc1c(-c2ccc(-c3c(C)noc3C)cc2)nc2ccccn12.Cc1ccc2nc(-c3ccc(-c4c(C)noc4C)cc3)c(NC(C)(C)C)n2c1.Cc1noc(C)c1-c1ccc(-c2nc3ccccn3c2NC(C)C)cc1.Cc1noc(C)c1-c1ccc(-c2nc3ccncn3c2NC(C)(C)C)cc1.Cc1noc(C)c1-c1ccc(-c2nc3ncccn3c2NC(C)(C)C)cc1
InChIInChI=1S/C23H26N4O.C22H24N4O.2C21H23N5O.C21H22N4O/c1-14-7-12-19-24-21(22(27(19)13-14)25-23(4,5)6)18-10-8-17(9-11-18)20-15(2)26-28-16(20)3;1-4-5-13-23-22-21(24-19-8-6-7-14-26(19)22)18-11-9-17(10-12-18)20-15(2)25-27-16(20)3;1-13-17(14(2)27-25-13)15-7-9-16(10-8-15)18-19(24-21(3,4)5)26-12-6-11-22-20(26)23-18;1-13-18(14(2)27-25-13)15-6-8-16(9-7-15)19-20(24-21(3,4)5)26-12-22-11-10-17(26)23-19;1-13(2)22-21-20(23-18-7-5-6-12-25(18)21)17-10-8-16(9-11-17)19-14(3)24-26-15(19)4/h7-13,25H,1-6H3;6-12,14,23H,4-5,13H2,1-3H3;2*6-12,24H,1-5H3;5-13,22H,1-4H3
InChIKeyAPUTVRMGGBCKAQ-UHFFFAOYSA-N
MW1804.28 g/mol
LogP26.13
Rot. Bonds19

About N-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyridin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-c]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-6-methylimidazo[1,2-a]pyridin-3-amine;2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-N-propan-2-ylimidazo[1,2-a]pyridin-3-amine

N-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyridin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-c]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-6-methylimidazo[1,2-a]pyridin-3-amine;2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-N-propan-2-ylimidazo[1,2-a]pyridin-3-amine (PubChem CID 157192056) has the molecular formula C108H118N22O5 and a molecular weight of 1804.28 g/mol. Its IUPAC name is N-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyridin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-c]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-6-methylimidazo[1,2-a]pyridin-3-amine;2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-N-propan-2-ylimidazo[1,2-a]pyridin-3-amine.

Molecular Properties

Compound NameN-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyridin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-c]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-6-methylimidazo[1,2-a]pyridin-3-amine;2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-N-propan-2-ylimidazo[1,2-a]pyridin-3-amine
PubChem CID157192056
Molecular FormulaC108H118N22O5
Molecular Weight1804.28 g/mol
Exact Mass1802.97
IUPAC NameN-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyridin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-c]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-6-methylimidazo[1,2-a]pyridin-3-amine;2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-N-propan-2-ylimidazo[1,2-a]pyridin-3-amine
SMILESCCCCNc1c(-c2ccc(-c3c(C)noc3C)cc2)nc2ccccn12.Cc1ccc2nc(-c3ccc(-c4c(C)noc4C)cc3)c(NC(C)(C)C)n2c1.Cc1noc(C)c1-c1ccc(-c2nc3ccccn3c2NC(C)C)cc1.Cc1noc(C)c1-c1ccc(-c2nc3ccncn3c2NC(C)(C)C)cc1.Cc1noc(C)c1-c1ccc(-c2nc3ncccn3c2NC(C)(C)C)cc1
InChIInChI=1S/C23H26N4O.C22H24N4O.2C21H23N5O.C21H22N4O/c1-14-7-12-19-24-21(22(27(19)13-14)25-23(4,5)6)18-10-8-17(9-11-18)20-15(2)26-28-16(20)3;1-4-5-13-23-22-21(24-19-8-6-7-14-26(19)22)18-11-9-17(10-12-18)20-15(2)25-27-16(20)3;1-13-17(14(2)27-25-13)15-7-9-16(10-8-15)18-19(24-21(3,4)5)26-12-6-11-22-20(26)23-18;1-13-18(14(2)27-25-13)15-6-8-16(9-7-15)19-20(24-21(3,4)5)26-12-22-11-10-17(26)23-19;1-13(2)22-21-20(23-18-7-5-6-12-25(18)21)17-10-8-16(9-11-17)19-14(3)24-26-15(19)4/h7-13,25H,1-6H3;6-12,14,23H,4-5,13H2,1-3H3;2*6-12,24H,1-5H3;5-13,22H,1-4H3
InChIKeyAPUTVRMGGBCKAQ-UHFFFAOYSA-N
XLogP26.13
TPSA302.58 Ų
H-Bond Donors5
H-Bond Acceptors27
Rotatable Bonds19
Heavy Atoms135
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001804.28
LogP ≤ 526.13
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1027

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyridin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-c]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-6-methylimidazo[1,2-a]pyridin-3-amine;2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-N-propan-2-ylimidazo[1,2-a]pyridin-3-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyridin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-c]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-6-methylimidazo[1,2-a]pyridin-3-amine;2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-N-propan-2-ylimidazo[1,2-a]pyridin-3-amine?
The IUPAC name of N-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyridin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-c]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-6-methylimidazo[1,2-a]pyridin-3-amine;2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-N-propan-2-ylimidazo[1,2-a]pyridin-3-amine (CID 157192056) is N-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyridin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-c]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-6-methylimidazo[1,2-a]pyridin-3-amine;2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-N-propan-2-ylimidazo[1,2-a]pyridin-3-amine.
What is the SMILES notation for N-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyridin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-c]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-6-methylimidazo[1,2-a]pyridin-3-amine;2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-N-propan-2-ylimidazo[1,2-a]pyridin-3-amine?
The canonical SMILES for N-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyridin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-c]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-6-methylimidazo[1,2-a]pyridin-3-amine;2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-N-propan-2-ylimidazo[1,2-a]pyridin-3-amine is CCCCNc1c(-c2ccc(-c3c(C)noc3C)cc2)nc2ccccn12.Cc1ccc2nc(-c3ccc(-c4c(C)noc4C)cc3)c(NC(C)(C)C)n2c1.Cc1noc(C)c1-c1ccc(-c2nc3ccccn3c2NC(C)C)cc1.Cc1noc(C)c1-c1ccc(-c2nc3ccncn3c2NC(C)(C)C)cc1.Cc1noc(C)c1-c1ccc(-c2nc3ncccn3c2NC(C)(C)C)cc1.
What is the InChIKey of N-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyridin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-c]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-6-methylimidazo[1,2-a]pyridin-3-amine;2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-N-propan-2-ylimidazo[1,2-a]pyridin-3-amine?
The InChIKey is APUTVRMGGBCKAQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H26N4O.C22H24N4O.2C21H23N5O.C21H22N4O/c1-14-7-12-19-24-21(22(27(19)13-14)25-23(4,5)6)18-10-8-17(9-11-18)20-15(2)26-28-16(20)3;1-4-5-13-23-22-21(24-19-8-6-7-14-26(19)22)18-11-9-17(10-12-18)20-15(2)25-27-16(20)3;1-13-17(14(2)27-25-13)15-7-9-16(10-8-15)18-19(24-21(3,4)5)26-12-6-11-22-20(26)23-18;1-13-18(14(2)27-25-13)15-6-8-16(9-7-15)19-20(24-21(3,4)5)26-12-22-11-10-17(26)23-19;1-13(2)22-21-20(23-18-7-5-6-12-25(18)21)17-10-8-16(9-11-17)19-14(3)24-26-15(19)4/h7-13,25H,1-6H3;6-12,14,23H,4-5,13H2,1-3H3;2*6-12,24H,1-5H3;5-13,22H,1-4H3.
What are the key properties of N-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyridin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-c]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-6-methylimidazo[1,2-a]pyridin-3-amine;2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-N-propan-2-ylimidazo[1,2-a]pyridin-3-amine?
N-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyridin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-c]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-6-methylimidazo[1,2-a]pyridin-3-amine;2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-N-propan-2-ylimidazo[1,2-a]pyridin-3-amine has a molecular weight of 1804.28 g/mol, XLogP of 26.13, 19 rotatable bonds, 5 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for N-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyridin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-a]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]imidazo[1,2-c]pyrimidin-3-amine;N-tert-butyl-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-6-methylimidazo[1,2-a]pyridin-3-amine;2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-N-propan-2-ylimidazo[1,2-a]pyridin-3-amine is sourced from PubChem (CID 157192056), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).